Access the full text.
Sign up today, get DeepDyve free for 14 days.
V. Simhadri, Aditi Banerjee, J. Simon, C. Kimchi-Sarfaty, Z. Sauna (2015)
Personalized approaches to the treatment of hemophilia A and B.Personalized medicine, 12 4
J. Dolan (2008)
Shared decision-making--transferring research into practice: the Analytic Hierarchy Process (AHP).Patient education and counseling, 73 3
G. Pierce (2020)
Uncertainty in an era of transformative therapy for haemophilia: Addressing the unknownsHaemophilia, 27
E. Rodríguez‐Merchán, L. Valentino (2018)
Emicizumab: Review of the literature and critical appraisalHaemophilia, 25
Nicoletta Machin, M. Ragni, Kenneth Smith (2018)
Gene therapy in hemophilia A: a cost-effectiveness analysis.Blood advances, 2 14
S. Treil, J. Rice, C. Leissinger (2007)
Quantifying adherence to treatment and its relationship to quality of life in a well‐characterized haemophilia populationHaemophilia, 13
L. Valentino (2014)
Considerations in individualizing prophylaxis in patients with haemophilia AHaemophilia, 20
Drug Bulletin (2013)
An introduction to patient decision aidsBMJ : British Medical Journal, 347
P. Collins (2012)
Personalized prophylaxisHaemophilia, 18
S. Gan, R. Calne (2006)
Gene therapy for hemophilia A.Discovery medicine, 6 35
A. Iorio, M. Skinner, E. Clearfield, D. Messner, G. Pierce, M. Witkop, S. Tunis, Ronald Akehurst, Mohit Jain, Edmund Pezalla, Leonard Valentino, Andreas Altemark, S. Belinson, Jason Booth, Philipp Dahm, Gerard Dolan, Karen Facey, Samantha Gouw, Daniel Hart, Anneliese Hilger, Craig Hooper, K. Hoots, James Jorgenson, Daniel Keene, Joanne Kim, S. Krassova, Gregory LeCleir, David Lillicrap, Maria Lopes, Peter Marks, Paul Monahan, Gyasi Moscou-Jackson, Jennifer Murray, M. Mujoomdar, Ellis Neufeld, J. O'Hara, B. O'Mahony, Marie Österberg, Charles Petrie, Vanita Pindolia, S. Pipe, Andreas Pleil, Philip Reilly, Ulrike Reiss, Michelle Rice, Sol Ruiz, Lew Sandy, Eileen Sawyer, Michael Sharp, Amy Sood, Clive Spiegler, P. Tugwell, A. Weill, Sophie Werkö, Wing Wong, Steven Zelenkofske, Jennifer Naber, Janelle King, Julie Simmons (2018)
Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder projectHaemophilia, 24
Mark Brimble, U. Reiss, A. Nathwani, A. Davidoff (2016)
New and improved AAVenues: current status of hemophilia B gene therapyExpert Opinion on Biological Therapy, 16
Natalie Joseph-Williams, Amy Lloyd, A. Edwards, L. Stobbart, D. Tomson, S. Macphail, Carole Dodd, K. Brain, G. Elwyn, R. Thomson (2017)
Implementing shared decision making in the NHS: lessons from the MAGIC programmeThe BMJ, 357
Fadi Nossair, C. Thornburg (2018)
The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countriesTherapeutic Advances in Hematology, 9
A. Srivastava, A. Brewer, E. Mauser-Bunschoten, N. Key, S. Kitchen, A. Llinás, C. Ludlam, J. Mahlangu, K. Mulder, M. Poon, A. Street (2013)
Guidelines for the management of hemophiliaHaemophilia, 19
V. Montori, A. Gafni, C. Charles (2006)
A shared treatment decision‐making approach between patients with chronic conditions and their clinicians: the case of diabetesHealth Expectations, 9
P. Moerloose, W. Urbancik, H. Berg, M. Richards (2008)
A survey of adherence to haemophilia therapy in six European countries: results and recommendationsHaemophilia, 14
G. Elwyn, D. Frosch, R. Thomson, Natalie Joseph-Williams, Amy Lloyd, P. Kinnersley, Emma Cording, D. Tomson, Carole Dodd, S. Rollnick, A. Edwards, M. Barry (2012)
Shared Decision Making: A Model for Clinical PracticeJournal of General Internal Medicine, 27
H. Sun, K. McIntosh, S. Squire, Ming Yang, Claude Bartholomew, D. Gue, P. Camp, S. Jackson (2017)
Patient powered prophylaxis: A 12‐month study of individualized prophylaxis in adults with severe haemophilia AHaemophilia, 23
Ana-Belén Río-Lanza, L. Suárez-Álvarez, A. Suárez-Vázquez, Rodolfo Vazquez-Casielles (2016)
Information provision and attentive listening as determinants of patient perceptions of shared decision-making around chronic illnessesSpringerPlus, 5
C. Thornburg, S. Carpenter, S. Zappa, J. Munn, C. Leissinger (2012)
Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United StatesHaemophilia, 18
J. Mahlangu, J. Powell, M. Ragni, P. Chowdary, N. Josephson, I. Pabinger, H. Hanabusa, N. Gupta, R. Kulkarni, P. Fogarty, D. Perry, A. Shapiro, K. Pasi, Shashikant Apte, I. Nestorov, Haiyan Jiang, Shuanglian Li, S. Neelakantan, L. Cristiano, J. Goyal, J. Sommer, J. Dumont, Nigel Dodd, Karen Nugent, G. Vigliani, A. Luk, Aoife Brennan, Glenn Pierce (2014)
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.Blood, 123 3
Emily Beers, Marci Nilsen, Jonas Johnson (2017)
The Role of Patients: Shared Decision-Making.Otolaryngologic clinics of North America, 50 4
S. Pipe (2018)
Gene therapy for hemophiliaPediatric Blood & Cancer, 65
G. Pierce, K. Pasi, D. Coffin, R. Kaczmarek, D. Lillicrap, J. Mahlangu, Dawn Rottellini, T. Sannié, A. Srivastava, T. VandenDriessche, A. Weill (2020)
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round TableHaemophilia, 26
E. Fillion (2003)
How is medical decision‐making shared? The case of haemophilia patients and doctors: the aftermath of the infected blood affair in FranceHealth Expectations, 6
R. Epstein (2013)
Whole mind and shared mind in clinical decision-making.Patient education and counseling, 90 2
J. Stoffman, N. Andersson, B. Branchford, K. Batt, R. d’Oiron, C. Ettingshausen, D. Hart, V. Yuste, K. Kavakli, M. Mancuso, K. Nogami, C. Ramirez, R. Wu (2018)
Common themes and challenges in hemophilia care: a multinational perspectiveHematology, 24
Kevin Klifto, C. Klifto, J. Slover (2017)
Current concepts of shared decision making in orthopedic surgeryCurrent Reviews in Musculoskeletal Medicine, 10
G. Perrin, R. Herzog, D. Markusic (2019)
Update on clinical gene therapy for hemophilia.Blood, 133 5
G. Lamiani, Sarah Bigi, M. Mancuso, A. Coppola, E. Vegni (2017)
Applying a deliberation model to the analysis of consultations in haemophilia: Implications for doctor-patient communication.Patient education and counseling, 100 4
A. Barratt (2008)
Evidence Based Medicine and Shared Decision Making: the challenge of getting both evidence and preferences into health care.Patient education and counseling, 73 3
V. Arruda, Bhavya Doshi, B. Samelson-Jones (2017)
Novel approaches to hemophilia therapy: successes and challenges.Blood, 130 21
K. High, M. Skinner (2011)
Cell phones and landlines: the impact of gene therapy on the cost and availability of treatment for hemophilia.Molecular therapy : the journal of the American Society of Gene Therapy, 19 10
Glenn Pierce, Alfonso Iorio (2018)
Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomesHaemophilia, 24
Michele Hacker, S. Geraghty, M. Manco‐Johnson (2001)
Barriers to compliance with prophylaxis therapy in haemophiliaHaemophilia, 7
Z. Berger (2015)
Navigating the Unknown: Shared Decision-Making in the Face of UncertaintyJournal of General Internal Medicine, 30
Katarina Hauser, A. Koerfer, K. Kuhr, C. Albus, Stefan Herzig, J. Matthes (2015)
Outcome-Relevant Effects of Shared Decision Making.Deutsches Arzteblatt international, 112 40
G. Elwyn, D. Frosch, S. Kobrin (2015)
Implementing shared decision-making: consider all the consequencesImplementation Science : IS, 11
AbstractThe current standard of care for treating people with haemophilia (PWH) in the developed world is prophylaxis with regular infusions of clotting factor concentrates. Gene therapy is being investigated as a new treatment paradigm for haemophilia and if approved would potentially eliminate the need for chronic, burdensome infusions. In recent years, shared decision making (SDM) has become increasingly common in patient care settings. SDM is a stepwise process that relies on reciprocal information sharing between the practitioner and patient, resulting in health care decisions stemming from the informed preferences of both parties. SDM represents a departure from the traditional, paternalistic clinical model where the practitioner drives the treatment decision and the patient passively defers to this decision. As the potential introduction of gene therapy in haemophilia may transform the current standard of care, and impact disease management and goals in unique ways, both practitioners and PWH may find their knowledge tested when considering the appropriate use of a novel technology. Therefore, it is incumbent upon haemophilia practitioners to foster an open, trusting, and supportive relationship with their patients, while PWH and their caregivers must be knowledgeable and feel empowered to participate in the decision making process to achieve truly shared treatment decisions.
The Journal of Haemophilia Practice – de Gruyter
Published: Jan 1, 2021
Keywords: Haemophilia; decision making; physician-patient relationships; decision support techniques; patient participation; patient-centred care; gene therapy
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.